In 102 patients placement of TIVAD via the cephalic vein cutdown approach was initially attempted, 87 patients underwent successful insertion while 15 required conversion to a percutaneous approach ...
A totally implantable venous access device (TIVAD) is necessary for cancer patients who require long-term intravenous chemotherapy. A research group in China investigated which factors reduced the ...
Different and long term chemotherapy treatments or nutritional support require a long term venous access in a cancer patient. Since 1982, the increasingly frequent use of TIVADs has reduced the burden ...
本研究通过FMEA和PDCA循环优化了TIVAD的风险管理，显著降低不可接受风险86%，验证了动态系统在资源有限医院的有效性。 在肿瘤学领域，用于给药细胞毒性药物的装置至关重要。其中，完全植入 ...
为探讨未冲管长期植入的完全植入式静脉输液港（TIVAD）情况，研究人员对 1995 - 2016 年植入患者展开研究。544 例中 93.4% 为实体瘤患者，部分未冲管 18 - 24 个月无堵塞，显示 TIVAD 可免冲管维持 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results